Phase 1 COPD trials recruiting now

All COPD trials, every phase

Other phases for COPD

Phase 1 COPD trials

• : Vascular Function in Health and Disease
  NCT02966665 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TQC3302 Inhalation Spray in Healthy Adult Subjects
  NCT07267130 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics for a Single Dose of HRS-9821 Powder for Inhalation and Inhalation Suspension Administered in Healthy Subjects and Multiple Doses in Patients With COPD.
  NCT07116915 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Phase I Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HRS-9821 Powder for Inhalation Administered as a Single Dose in Healthy Participants and Multiple Doses in Patients With COPD
  NCT07567872 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)
  NCT06944925 · Phase: Phase 1 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 14 locations
• A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Obstructive Pulmonary Disease (COPD)
  NCT07288554 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 11 locations
• A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of KIT2014 in Patients With Moderate to Severe COPD
  NCT07668518 · Phase: Phase 1, Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 2 locations
• A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
  NCT06603246 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• Efficacy of Morphine in Reducing the Rate of Early Non-Invasive Ventilation Failure in Acute Exacerbation of Chronic Obstructive Pulmonary Disease, Phase I/IIa
  NCT04427826 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Feasibility of Semaglutide in Advanced Lung Disease
  NCT05746039 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Hyper Polarized Xenon-129 MRI vs Xenon-133 Scintigraphy
  NCT03331302 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
  NCT04624490 · Phase: Phase 1 · Ages: 3 Years and older · Sex: All (male and female) · 2 locations
• Impact of Eradication Therapy on Helicobacter Pylori Infection With Chronic Obstructive Pulmonary Disease:
  NCT07574879 · Phase: Phase 1 · Ages: 40 Years and older · Sex: All (male and female) · 1 location
• Impact of Long-acting Bronchodilator- -Corticoid Inhaled Therapy on Ventilation, Lung Function and Breathlessness
  NCT06110403 · Phase: Phase 1, Phase 2 · Ages: 40 Years to 75 Years · Sex: All (male and female) · 1 location
• Inhaled RB042 in Healthy Adult Volunteers, Healthy Adult Smokers and Patients With Chronic Obstructive Pulmonary Disease
  NCT07285122 · Phase: Phase 1 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Investigation of Small Mobile Stem Cells (SMS Cells) in Participants With Chronic Obstructive Pulmonary Disease (COPD).
  NCT06986070 · Phase: Phase 1 · Ages: 39 Years to 69 Years · Sex: All (male and female) · 1 location
• Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure
  NCT03500731 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 2 locations
• REGEND001 Autologous Basal Layer Stem Cell Transplantation for Chronic Obstructive Pulmonary Disease (COPD): A Translational Application Study
  NCT06946953 · Phase: Phase 1, Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 2 locations
• Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Pulmonary Diseases
  NCT05147688 · Phase: Phase 1 · Ages: No age limits stated · Sex: All (male and female) · 2 locations
• To Identify if a COPD Self-management App Can Safety and Appropriately Identify When Patients Are Not on the Best Medication Plan for Their COPD Symptoms and Support Their COPD Management.
  NCT07797985 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• cfMSC Stem Cell Therapy Targeting COPD
  NCT07477600 · Phase: Phase 1, Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 1 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.